My broker says earnings are "the week of August 2nd". Anybody have a date for that? We are 10-15 trading days from hearing the initial financial impact of Kadcyla which is probably the reason for this move.
IMGN is paid by Roche one quarter behind, so the sales release from Roche is far more important than the earnings release. Also, July 25 is an important date according to posters on the IV board. It's good to see the current quarter estimate is -.3, I expect costs to increase faster than revs for at least the next 1-2 quarters until sales kick in and add in the quarter delay. They currently have at least 2 years of cash, so hopefully no offerings will be needed until/unless they decide to do an advanced clinical trial.